| Serial Number | 79273317 |
| Word Mark | BELESALA |
| Filing Date | Tuesday, September 10, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 27, 2020 |
| Registration Number | 6182097 |
| Registration Date | Tuesday, October 27, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 11, 2020 |
| Goods and Services | Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; medical device, namely, medical syringes used for manual injection |
| Goods and Services | Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; syringes sold prefilled with pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders, and intravenous analgesics and antipyretics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2019 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | IE |
| Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | IE |
| Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | IE |
| Event Date | Event Description |
| Thursday, December 5, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 6, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 10, 2019 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, December 11, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, December 11, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, December 12, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, January 21, 2020 | REFUSAL PROCESSED BY MPU |
| Tuesday, January 21, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, February 8, 2020 | REFUSAL PROCESSED BY IB |
| Monday, July 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 6, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 6, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 7, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 7, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 7, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 7, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 7, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 22, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 22, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, July 22, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, August 7, 2020 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 11, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 11, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 27, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 27, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, February 11, 2021 | GENERIC MADRID TRANSACTION CREATED |
| Thursday, February 11, 2021 | GENERIC MADRID TRANSACTION SENT TO IB |
| Sunday, April 4, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sunday, January 21, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, October 27, 2025 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |